Last reviewed · How we verify
NCT05908864
Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation
trial testing Magnesium sulfate in Asthma Attack in 123 participants. Completed in 15 December 2020.
22 November 2019
Quick facts
| Lead sponsor | Beni-Suef University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 123 |
| Start date | 30 October 2018 |
| Primary completion | 22 November 2019 |
| Estimated completion | 15 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Magnesium sulfate — full drug profile →
Conditions studied
- Asthma Attack — all drugs for Asthma Attack →
Sponsor
Beni-Suef University
Who can join
Adults 18 to 50, any sex, with Asthma Attack. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective study in Beni-Seuf University Hospital that was conducted on 123 adult patients with acute asthma exacerbations. Patients were classified into group (I): received IV magnesium sulfate, group (II): received nebulized magnesium sulfate, and group (III): control group. Blood pressure, respiratory rate, pulse, peak expiratory flow rate (PEFR) measurement using a peak flowmeter, Fischl index and need for hospitalization in patients with acute bronchial asthma were done for all patients before treatment, immediately after the treatment, "30", and "60" min after treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05908864
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnesium sulfate
Trials testing the same drug.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07438366 — Adding Magnesium Sulphate to Combined Pectointercostal Plane and Erector Spinae Plane Blocks for Acute and Chronic Post- · NA · not yet recruiting
- NCT07213037 — Magnesium Sulfate Versus Lidocaine as Additives to Dexmedetomidine for Cough Suppression After Functional Endoscopic Sin · Phase 3 · not yet recruiting
- NCT06979141 — Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia · Phase 3 · recruiting
- NCT07131033 — Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholec · Phase 1, PHASE2 · active not recruiting
Other recruiting trials for Asthma Attack
Currently open trials in the same condition.
- NCT07129616 — Remote Monitoring of Asthma in Children and Young People · recruiting
- NCT07052942 — Individualizing Treatment for Asthma in Primary Care (Full Study) · Phase 4 · recruiting
- NCT06734793 — Wearable Electronic Breath Sound Sensing Device · recruiting
- NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting
- NCT06137040 — Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation · EARLY_PHASE1 · recruiting
Other Beni-Suef University trials
Trials by the same sponsor.
- NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
- NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
- NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
- NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05908864 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
- Last refreshed: 18 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05908864.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing